GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » Gross Margin %

Braxia Scientific (XCNQ:BRAX) Gross Margin % : 16.67% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Braxia Scientific's Gross Profit for the three months ended in Dec. 2023 was C$0.08 Mil. Braxia Scientific's Revenue for the three months ended in Dec. 2023 was C$0.49 Mil. Therefore, Braxia Scientific's Gross Margin % for the quarter that ended in Dec. 2023 was 16.67%.


The historical rank and industry rank for Braxia Scientific's Gross Margin % or its related term are showing as below:

XCNQ:BRAX' s Gross Margin % Range Over the Past 10 Years
Min: 9.13   Med: 14.48   Max: 16.61
Current: 14.67


During the past 3 years, the highest Gross Margin % of Braxia Scientific was 16.61%. The lowest was 9.13%. And the median was 14.48%.

XCNQ:BRAX's Gross Margin % is ranked worse than
86.78% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs XCNQ:BRAX: 14.67

Braxia Scientific had a gross margin of 16.67% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Braxia Scientific was 0.00% per year.


Braxia Scientific Gross Margin % Historical Data

The historical data trend for Braxia Scientific's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific Gross Margin % Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
Gross Margin %
14.48 16.61 9.13

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 4.79 14.67 21.72 16.67

Competitive Comparison of Braxia Scientific's Gross Margin %

For the Biotechnology subindustry, Braxia Scientific's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's Gross Margin % falls into.



Braxia Scientific Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Braxia Scientific's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=0.2 / 1.884
=(Revenue - Cost of Goods Sold) / Revenue
=(1.884 - 1.712) / 1.884
=9.13 %

Braxia Scientific's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0.1 / 0.492
=(Revenue - Cost of Goods Sold) / Revenue
=(0.492 - 0.41) / 0.492
=16.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Braxia Scientific  (XCNQ:BRAX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Braxia Scientific had a gross margin of 16.67% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Braxia Scientific Gross Margin % Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines